UPC Universe Pharmaceuticals INC stock chart & analysis
Conviction 45HealthcareScan · Tue, Nov 17, 2026Universe Pharmaceuticals INC (UPC) closed at $1.48 (+0.00%) on Nov 17, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 27, RS Rating 16, -91.8% from its 52-week high, -61.2% year to date. Sector: Healthcare.
Why UPC moved
From the StockSetups movers recaps that covered UPC, newest first. A recap states what was known that day.
- Premarket+115.5%
Universe Pharmaceuticals is surging +115.5% to $7.22 in premarket trading on a staggering 11.79 million shares — nearly 97× its 20-day average volume of just 122,270 shares.
Premarket Stock Movers — August 3, 2026: Why UPC, EZRA, DFNS, FCUV & ATKR Are Surging → - Close+308.4%
According to a Yahoo Finance headline dated June 26, Universe Pharmaceuticals announced a strategic acquisition to expand its pharmaceutical patent portfolio. That news hit after hours on Friday, triggering the massive gap visible in Monday's session.
Top Stock Movers Today — June 29, 2026: Why UPC, SDOT, DGNX, AZI & CBRG Surged →
UPC technical analysis
Trend
UPC is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 57.0% below the 50-day ($3.44) and 59.5% below the 200-day ($3.65). The 50-day crossed below the 200-day (a death cross) 4 sessions ago. ADX(14) at 34 points to a strong, established trend. It meets 1 of 8 trend-template criteria.
Momentum
RSI(14) is 27, in oversold territory. MACD crossed above its signal line 2 sessions ago. Its RS Rating of 16 puts its weighted 12-month performance ahead of about 16% of the US market.
Volume and volatility
Volume on the latest session ran 0.1× its 20-day average. It trades about $409,734 a day on average. ATR(14) is $0.2926, 19.8% of price — its typical daily range. On-balance volume is trending down. Chaikin Money Flow (-0.55) shows distribution.
Key levels
The chart pattern's support is $1.38 and its resistance $4.83. The 52-week range is $1.33 to $17.96; price is 91.8% below the high and 11.3% above the low. The VWAP anchored at the 52-week high is $9.23, above price.
Performance
UPC returned -4.5% (1 week), -60.6% (1 month), -72.3% (3 months), -41.7% (6 months), -59.5% (1 year), -61.2% (year to date).
About Universe Pharmaceuticals INC
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
Listed 2021 · 216 employees
Insider activity
SEC Form 4 transactions in UPC
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Lai Gang Chief Executive Officer · Class A ordinary shares, par value US$0.00001 per share · 2026-05-07 | Grant | 71.89K | — | 2026-05-07 | 2026-05-21 |
Lai Gang Chief Executive Officer · Class B ordinary shares, par value US$0.00001 per share · 2026-05-07 | Grant | 12.61K | — | 2026-05-07 | 2026-05-21 |
Lai Gang Chief Executive Officer · Class B ordinary shares, par value US$0.00001 per share · 2026-05-07 | Other | — | — | 2026-05-07 | 2026-05-21 |
SEC filings
EDGAR filings in UPC · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.